Instrumento Inactivo

Otros idiomas OXFORD BIOMEDICA Swiss Exchange

Acciones

Oxford Biomedica : Rules of the Oxford Biomedica 2024 Sharesave Scheme	15/05
Oxford Biomedica : Rules of the Oxford Biomedica 2024 Long Term Incentive Plan	15/05
Oxford Biomedica : Rules of the Oxford Biomedica 2024 Deferred Bonus Plan	15/05
Oxford Biomedica : 2024 Notice of Annual General Meeting	15/05
Oxford Biomedica : 2024 Notice of Annual General Meeting 15 May 2024	15/05
Avon Protection wins UK MoD supply deal; Molten Ventures up	09/05
Molten Ventures wins UK MoD supply contract	09/05
NatWest target raised, other lenders backed	09/05
Oxford Biomedica : Preliminary Results of the year ended 31 December 2023 29 April 2024	08/05
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	03/05
FTSE 100 as investors look to Fed rate decision	29/04
Oxford Biomedica : Preliminary results for the year ended 31 December 2023 29 April 2024	29/04
Oxford BioMedica bullish; Petrofac slumps	29/04
Earnings Flash (OXB.L) OXFORD BIOMEDICA Reports FY23 Revenue GBP89.5M	29/04
Oxford Biomedica plc Reiterates Earnings Guidance for the Year 2024	29/04
Oxford Biomedica plc Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
HSBC likes Haleon, cuts Flutter to 'hold'	18/04
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	20/03
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs	20/03
Oxford Biomedica plc Announces Board Changes	11/03

No hay resultados para esta búsqueda